As a result, supplementation with free GAH gave no distinguishable difference in LD antitumour activity, indicating that the ILD antitumour effect resulted from the conjugation of the antibody onto liposomes, and not synergistic activities of LD and antibody, nor the result of modulation of drug sensitivity caused by antibodies. This evidence concerns the gene GDA and interstitial lung disease.